Mother Screening for Relapse Using Mid-upper Arm Circumference Among Children Recovered From Severe Acute Malnutrition

Sponsor
University of California, San Francisco (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05932992
Collaborator
Centre de Recherche en Santé de Nouna (Other)
400
1
2
12
33.3

Study Details

Study Description

Brief Summary

The investigators propose a pilot randomized controlled trial to train mothers to screen their children post-discharge for relapse based on MUAC criteria to facilitate timely identification and referral to care for children who have relapsed.

Condition or Disease Intervention/Treatment Phase
  • Other: Mother education on how to perform MUAC assessment
N/A

Detailed Description

While interventions prioritizing rapid weight gain have led to improved survival for children with severe acute malnutrition (SAM), prevention of relapse to SAM after recovery is essential to improve long-term outcomes for children beyond survival. Mothers have been successfully trained to screen for new-onset SAM in community-based settings and perform as well as community health workers for detecting SAM. Here, the investigators propose a pilot randomized controlled trial in which mothers will be trained to screen their children post-discharge for relapse based on MUAC criteria to facilitate timely identification and referral to care for children who have relapsed.

SPECIFIC AIM 1: Determine the feasibility of training mothers to screen for relapse among children recovering from SAM compared to standard of care for early detection of relapse and re-entry to care. The investigators hypothesize that relapse will be detected earlier in children whose mothers have been trained to screen for relapse compared to standard of care (no mother screening).

Specific Aim 1A: Determine the burden of post-discharge relapse among children recovered from an episode of SAM in Boromo, Burkina Faso. The investigators hypothesize that >25% of children who have recovered from SAM in the study facilities will relapse within a 6-month period following their discharge.

Specific Aim 1B: Determine the acceptability and feasibility of training mothers to screen for relapse after discharge among children recovered from SAM. the investigators hypothesize that mothers will find MUAC screening acceptable and that training them will be feasible, as demonstrated by time and costs for training, willingness to participate in training, and follow-up in the trial.

SPECIFIC AIM 2: Determine the accuracy of mother-based screening for relapse among children recovering from SAM compared to a gold standard anthropometrist. the investigators hypothesize that mother screening will have a sensitivity and specificity of > 80% for the detection of relapsed SAM (MUAC < 11.5 cm) compared to screening by a trained anthropometrist.

the investigators anticipate that the result of this pilot will provide evidence supporting the acceptability, feasibility, and accuracy of mother screening for relapse among children with SAM. The data generated during this pilot will be used to support the development of a full-scale randomized controlled trial and will be used as preliminary data supporting an R01-level NIH application. These data will help establish a new line of work for our research team in the management of acute malnutrition, which builds on existing expertise in randomized controlled trials and antibiotic-based interventions for child survival and reduction of morbidity, including as part of the management of uncomplicated SAM.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trial of mothers being trained to measure MUAC vs standard of care to prevent relapseRandomized controlled trial of mothers being trained to measure MUAC vs standard of care to prevent relapse
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
Outcomes assessor and investigator will be masked to intervention. In regards to the intervention, participants and care providers won't be masked.
Primary Purpose:
Prevention
Official Title:
Mother Screening for Relapse Using Mid-upper Arm Circumference Among Children Recovered From Severe Acute Malnutrition
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Mother screening

In this arm, mothers / children dyads will be enrolled. Mothers will be trained to measure mid-upper arm circumference (MUAC) on their children weekly for 6 months. All other standard care will be provided.

Other: Mother education on how to perform MUAC assessment
Mothers will be trained to perform MUAC weekly on their children

No Intervention: standard of care

In this arm, mothers / children dyads will be enrolled. No study intervention will be performed. all other standard of care will be provided.

Outcome Measures

Primary Outcome Measures

  1. Time to detection of relapse [6 months]

    Time to relapse using a log-rank test with a term for randomized treatment assignment will be used. Relapse will be defined using the Burkina Faso guideline for detecting malnutrition (MUAC < 11.5 cm and / or weight-for-height Z-scores WHZ < -3 SD)

Secondary Outcome Measures

  1. Weight for Height Z score (WHZ) [6 months]

    Weight for Height Z score will be calculated and compared between arms

  2. weight-for-age Z-score (WAZ) [6 months]

    weight-for-age Z-score will be calculated and compared between arms

  3. height-for-age Z-score (HAZ) [6 months]

    height-for-age Z-score will be calculated and compared between arms

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Months to 59 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Child is 6-59 months of age;

  • Child has recovered from an episode of SAM per Burkinabè national guidelines

  • Family is planning to stay in the study area for 6 months;

  • Appropriate consent is obtained

Exclusion Criteria:
  • Child is less than 6 months of age or more than 59 months of age

  • Child didn't recover from an episode of SAM

  • Family is not planning on staying in the area for 6 months

  • Consent for participation is not obtained

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre de recherche en sante de nouna Nouna Burkina Faso

Sponsors and Collaborators

  • University of California, San Francisco
  • Centre de Recherche en Santé de Nouna

Investigators

  • Principal Investigator: Catherine Oldenburg, ScD, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT05932992
Other Study ID Numbers:
  • 23-38829
First Posted:
Jul 6, 2023
Last Update Posted:
Jul 6, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2023